AffyImmune Therapeutics
PrivateLast Round
Series A
Oct 7, 2021
Total Funding Raised
$38.55M
Company Overview
AffyImmune Therapeutics operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Series A round in October 2021.
AffyImmune Therapeutics is a biotechnology company that develops affinity-tuned CAR T cell therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AffyImmune Therapeutics Comparables
Compare AffyImmune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovative Cellular Therapeutics | 87% | |
| Bio4t2 | 87% | |
| Leucid Bio | 85% |
For institutional investors. Book with your work email.
AffyImmune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2021 | ||||
| Grant | May 25, 2021 | ||||
| Series A | Nov 28, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AffyImmune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Cornell University Office of University Investments | Series A |
| ORI Capital | Series A |
AffyImmune Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AffyImmune Therapeutics's valuation, stock price, and market status.
Is AffyImmune Therapeutics a public or private company?
AffyImmune Therapeutics is a private company.
What is the current stock price of AffyImmune Therapeutics?
AffyImmune Therapeutics is a private company, so its shares have no public market price. Caplight tracks AffyImmune Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AffyImmune Therapeutics worth (valuation)?
Valuation information for AffyImmune Therapeutics is not publicly available.
Can I buy AffyImmune Therapeutics stock?
AffyImmune Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AffyImmune Therapeutics's last funding round?
AffyImmune Therapeutics's most recent funding round was Series A on October 7, 2021.
Who are the main investors in AffyImmune Therapeutics?
Key investors in AffyImmune Therapeutics include ORI Capital.
Will AffyImmune Therapeutics IPO soon?
No public IPO plans have been announced for AffyImmune Therapeutics.
How can I track AffyImmune Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AffyImmune Therapeutics's shares on secondary markets.